Profile
| Role | Insider |
|---|---|
| Notability | 30/100 |
Updated Jul 16, 2026
Hemrajani Rekha has filed 3 SEC Form 4 filings across 3 companies in the last 90 days — active on both sides. Lifetime open-market purchases: $46K. Lifetime open-market sales: $22K.
| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-22 | MXCT | MAXCYTE, INC. | A — Grant or award | 30.4K | $0.00 | |
| 2025-06-25 | MXCT | MAXCYTE, INC. | S — Open-market sale | 10.7K | $2.09 | $22K |
| 2025-06-18 | MXCT | MAXCYTE, INC. | A — Grant or award | 29.2K | $0.00 | |
| 2024-12-04 | ALXO | ALX ONCOLOGY HOLDINGS INC | P — Open-market purchase | 30.0K | $1.55 | $46K |
Hemrajani Rekha is a corporate insider — currently tracked as Insider of MAXCYTE, INC. (MXCT). InsiderAlpha tracks every SEC Form 4 filing in real time.
3 primary Form 4 filings in the last 90 days, covering 3 companies.
Recorded transactions: 1 open-market purchases ($46K) and 1 open-market sales ($22K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Hemrajani Rekha profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.